Figma and DaVita Face Market Scrutiny Amid Shifting SaaS and Healthcare Dynamics
Institutional analysts are intensifying their scrutiny of Figma and DaVita as both companies navigate pivotal transitions in the SaaS and healthcare sectors. While Figma solidifies its post-IPO independence through AI-driven design tools, DaVita is increasingly leveraging cloud-based predictive analytics to maintain its dominance in the dialysis market.